SAN DIEGO — Preliminary data from a 3-year, phase 3 clinical trial of Vyluma’s NVK002 supported its safety and efficacy as a potential treatment for myopia progression in children, according to a ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Mark A. Bullimore, MCOptom, PhD, FAAO, ...
Over 24 months, kids using the once-nightly drops and those using placebo saw mean changes in spherical equivalent refractive error (SER) of -0.82 D (95% CI -0.96 to ...
Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...
Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...
About The Study: In this randomized clinical trial of school-age children in the U.S. with low to moderate myopia (nearsightedness), atropine, 0.01%, eye drops administered nightly when compared with ...
BRIDGEWATER, N.J., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets for the treatment of refractive errors, today announced top-line ...
Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...
The US Food and Drug Administration has authorized marketing of the first eyeglass lenses that not only correct nearsightedness in children, they can slow the progression of the condition.
A2Z Eyecare (201-559-3977) has expanded its range of juvenile-onset myopia control treatments to Ridgewood, NJ, in response ...
Dilating eyedrops may delay ― and perhaps even prevent ― the onset of myopia in children, according to findings from a study published today in JAMA. The study was conducted by researchers in Hong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results